Dr Dave Coman
Dr

Dave Coman

Email: 

Background

David is a Consultant Paediatrician, Metabolic Physician, Clinical Geneticist and clinician researcher. His area of expertise is the diagnosis and management of children with rare diseases. David is involved in multiple ongoing research projects aimed at novel disease discovery, improved diagnostic testing and treatments for children with inherited genetic disorders. He is director of a national clinic for Ataxia Telangiectasia brashat.org.au and has recently been awarded a $2.5 million NHMRC research grant for a phase 2/3 trial for treatment of this disorder.

Availability

Dr Dave Coman is:
Available for supervision

Fields of research

Biological Sciences Biomedical and Clinical Sciences Clinical sciences Developmental genetics (incl. sex determination) Gene expression (incl. microarray and other genome-wide approaches) Genetics Genomics Medical biochemistry - amino acids and metabolites Medical biochemistry and metabolomics Medical genetics (excl. cancer genetics) Metabolic medicine Paediatrics

Qualifications

  • Australian Health Practitioner Regulation Agency, Australian Health Practitioner Regulation Agency
  • Australian Medical Association, Australian Medical Association
  • Human Genetics Society of Australasia, Human Genetics Society of Australasia
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians
  • Society for the Study of Inborn Errors of Metabolism, Society for the Study of Inborn Errors of Metabolism

Research impacts

David has close relationships with research colleagues both in Australia and internationally. He has multiple ongoing research projects investigating novel disease identification, the genetics of paediatric speech disorders and the development of new therapeutic possibilities for children and adults with rare diseases.

Search Professor Dave Coman’s works on UQ eSpace

122 works between 2005 and 2025
All (122) Journal Article (107) Book Chapter (6) Conference Publication (9)

121 - 122 of 122 works

2005

Journal Article

Congenital disorder of glycosylation type Ia in a 6-year-old girl with a mild intellectual phenotype: Two novel PMM2 mutations

Coman, David, Klingberg, S., Morris, D., McGill, J. and Mercer, H. (2005). Congenital disorder of glycosylation type Ia in a 6-year-old girl with a mild intellectual phenotype: Two novel PMM2 mutations. Journal of Inherited Metabolic Disease, 28 (6), 1189-1190. doi: 10.1007/s10545-005-0166-y

Congenital disorder of glycosylation type Ia in a 6-year-old girl with a mild intellectual phenotype: Two novel PMM2 mutations

2005

Journal Article

Severe hypernatraemic dehydration in a breast-fed neonate

Coman, David and Mercer, Hilary (2005). Severe hypernatraemic dehydration in a breast-fed neonate. Journal of Paediatrics and Child Health, 41 (8), 458-459. doi: 10.1111/j.1440-1754.2005.00670.x

Severe hypernatraemic dehydration in a breast-fed neonate

Current funding

  • 2024 - 2027
    Metabolic Medicine Research Clinical Trial in Ataxia-Telangiectasia
    BrAshA-T Ataxia-Telangiectasia Research Funding
    Open grant
  • 2023 - 2028
    Introducing Mitochondrial Donation into Australia: The mitoHOPE (Healthy Outcomes Pilot and Evaluation) Program (MRFF EPCDRI grant led by Monash)
    Monash University
    Open grant
  • 2023 - 2028
    Translational Centre for Speech Disorders (NHMRC Centre of Research Excellence administered by Murdoch Children's Research Institute)
    Murdoch Childrens Research Institute
    Open grant
  • 2021 - 2025
    Mitochondrial Diagnostic Network for Genomics and Omics - Not being led through UQ.
    Murdoch Childrens Research Institute
    Open grant
  • 2020 - 2025
    Ataxia-telangiectasia: treating mitochondrial dysfunction with a novel form of anaplerosis
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2021 - 2024
    Repairing catalase function in A-T patients using a CAT-SKL therapeutic
    National Stem Cell Foundation of Australia Matched Funding Program
    Open grant
  • 2020 - 2023
    A Phase 2A/2B placebo-controlled randomised clinical trial to test the ability of triheptanoin to protect primary airway epithelial cells obtained from patients with ataxia-telangiectasia against....
    BrAshA-T Ataxia-Telangiectasia Research Funding
    Open grant
  • 2020 - 2022
    Ataxia-telangiectasia: treating mitochondrial dysfunction with a novel form of anaplerosis
    Wesley Medical Research Ltd
    Open grant
  • 2011 - 2013
    Early prediction of intellectual and cognitive-linguistic outcomes in children with treated galactosaemia
    APEX Foundation for Research into Intellectual Disability Ltd (AFRID)
    Open grant

Availability

Dr Dave Coman is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Enquiries

For media enquiries about Dr Dave Coman's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au